Literature DB >> 6416852

Increased tight junction permeability: a possible mechanism of oestrogen cholestasis.

E Elias, S Iqbal, S Knutton, A Hickey, R Coleman.   

Abstract

Ethinyl oestradiol increased rat biliary permeability for 3H-inulin and 14C-sucrose, and significantly raised serum concentrations of bile acids after 3 and 7 days' treatment (P less than 0.0005) and bilirubin after 7 days (P less than 0.005) but not after 3 days. Following intravenous infusion of bromsulphthalein or phenolphthalein, ethinyl oestradiol-treated rats had elevated plasma concentrations of the three bile constituents, bromsulphthalein (P less than 0.0005 after 3 and 7 days), bromsulphthalein-glutathione conjugate (P less than 0.005 after 3 days; P less than 0.0005 after 7 days) and phenolphthalein glucuronide (P less than 0.005 after 3 days; P less than 0.0005 after 7 days), but the plasma concentration of unconjugated phenolphthalein, which was undetectable in bile, was unchanged. Similar changes followed partial biliary obstruction produced by bile cannula elevation. This pattern suggests that biliary constituents are refluxing from bile to plasma via the paracellular pathway, a concept further supported by structural changes in tight junction morphology in the oestrogen-treated rats. 'Leakiness' of canalicular tight junctions may explain the pathophysiology of oestrogen-induced cholestasis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416852     DOI: 10.1111/j.1365-2362.1983.tb00118.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  8 in total

Review 1.  Biochemistry of bile secretion.

Authors:  R Coleman
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

2.  Oestradiol 17 beta-glucuronide increases tight-junctional permeability in rat liver.

Authors:  K S Kan; M J Monte; R A Parslow; R Coleman
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

3.  Drug-induced intrahepatic cholestasis: characterization of different pathomechanisms.

Authors:  H Krell; J Metz; H Jaeschke; H Höke; E Pfaff
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

Review 4.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

Review 5.  Women and primary biliary cirrhosis.

Authors:  Ying Sun; Krista Haapanen; Baosen Li; Weici Zhang; Judy Van de Water; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 6.  Cholestasis-induced alterations of the trans- and paracellular pathways in rat hepatocytes.

Authors:  L Landmann
Journal:  Histochem Cell Biol       Date:  1995-01       Impact factor: 4.304

7.  Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.

Authors:  Lucie Muchova; Katerina Vanova; Jakub Suk; Stanislav Micuda; Eva Dolezelova; Leos Fuksa; Dalibor Cerny; Hassan Farghali; Miroslava Zelenkova; Martin Lenicek; Ronald J Wong; Hendrik J Vreman; Libor Vitek
Journal:  J Cell Mol Med       Date:  2015-02-16       Impact factor: 5.310

Review 8.  Rodent models of cholestatic liver disease: A practical guide for translational research.

Authors:  Eva Gijbels; Alanah Pieters; Kevin De Muynck; Mathieu Vinken; Lindsey Devisscher
Journal:  Liver Int       Date:  2021-02-23       Impact factor: 5.828

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.